Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
3
×
life sciences
national blog main
deals
national top stories
san francisco blog main
startups
alnylam pharmaceuticals
alphabet
beijing
boston
brii bio
brii biosciences
broad institute of harvard and mit
brook byers
cancer
charles chu
china
clinical trials
codiak biosciences
crispr
crispr cas14
cutaneous t-cell lymphoma
decheng capital
diagnostic
exosome
glaxosmithkline
google
gsk
hepatitis b
infectious disease
investing
jazz pharmaceuticals
kleiner perkins
mammoth biosciences
mayfield
medical devices
new york blog main
What
biosciences
3
×
based
bio’s
medicines
million
new
tiny
adds
alliance
areas
available
begin
big
bio
brii
brings
bubbles
cas
cells
cheaper
class
clinical
codiak
crispr
develop
diagnostics
disease
drug
earlier
exosome
exosomes
expects
faster
formed
fund
hepatitis
infectious
ipo
launched
mammoth
Language
unset
Current search:
biosciences
×
" boston top stories "
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
